We wish to add an additional suggestion to the "AASLD Practice Guidelines: Primary Biliary Cirrhosis" that was published last month in HEPATOLOGY 1 and of which we were coauthors. Approximately 40% of patients with primary biliary cirrhosis (PBC) respond incompletely to treatment with ursodiol. Bec
β¦ LIBER β¦
Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol
β Scribed by Peter A.L. Bonis; Marshall Kaplan
- Book ID
- 119755865
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 106 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment with immunosuppressives in pat
β
Marshall M. Kaplan; Raoul Poupon
π
Article
π
2009
π
John Wiley and Sons
π
English
β 45 KB
Methotrexate therapy for the symptomatic
β
M. A. BABATIN; F. M. SANAI; M. G. SWAIN
π
Article
π
2006
π
John Wiley and Sons
π
English
β 480 KB
Efficacy of colchicine in patients with
β
Young Mee Lee; Marshall M Kaplan
π
Article
π
2003
π
Nature Publishing Group
π
English
β 57 KB
Atorvastatin in patients with primary bi
β
Tatjana Stojakovic; Csilla Putz-Bankuti; GΓΌnter Fauler; Hubert Scharnagl; Martin
π
Article
π
2007
π
John Wiley and Sons
π
English
β 207 KB
π 1 views
Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of
Positive responses to methotrexate and u
β
Hans-Peter Buscher; Yvonne Zietzschmann; Wolfgang Gerok
π
Article
π
1993
π
Elsevier Science
π
English
β 471 KB
Biochemical and immunologic effects of r
β
Masanobu Tsuda; Yuki Moritoki; Zhe-Xiong Lian; Weici Zhang; Katsunori Yoshida; K
π
Article
π
2012
π
John Wiley and Sons
π
English
β 904 KB